Physician profile
Zeynep Gul
NPI 1073909768
$3,389.54
in general payments reported to CMS, 2019-2025
19 companies · $2,227 in 2025
The $2,227 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $206 · 2022: $121 · 2023: $325 · 2024: $510 · 2025: $2,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912 · Consulting Fee: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.97 |
| Consulting Fee | $1,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $1,505.18 | 2025 | Erleada |
| Boston Scientific Corporation | $676.76 | 2020-2025 | Lithovue, Ams 700, Lithoclast |
| Urogen Pharma, INC. | $222.04 | 2024-2025 | |
| Calyxo, INC. | $186.41 | 2025 | Cvac Aspiration System |
| Integra Lifesciences Corporation | $129.15 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nuo Therapeutics | $117.45 | 2023 | |
| 180 Medical, INC. | $111.73 | 2023-2025 | |
| Intuitive Surgical, INC. | $104.37 | 2023 | |
| Procept Biorobotics Corporation | $55.59 | 2025 | |
| Medtronic, INC. | $48.25 | 2024 | Signia |
| Teleflex LLC | $39.51 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $29.96 | 2025 | Orgovyx |
| Endo USA, INC. | $29.51 | 2024 | Xiaflex |
| Acera Surgical, INC. | $29.09 | 2024 | Restrata Wound Matrix |
| Myriad Genetic Laboratories, INC. | $26.25 | 2023 | Prolaris |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.67 | 2025 | Keytruda, Welireg |
| Abc Home Medical Supply, INC. | $20.64 | 2025 | |
| Tolmar, INC. | $17.93 | 2023 | |
| Solventum Corporation | $15.05 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zeynep Gul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.